Vanguard Group
SRGA

Vanguard Group’s Surgalign Holdings, Inc. Common Stock SRGA Stock Holding History

Vanguard Group’s Portfolio SRGA Stock Details SRGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-177,793
Closed -$284K – 4643
2023
Q1 		$284K Hold
177,793
– – ﹤0.01% 4263
2022
Q4 		$354K Buy
177,793
+82
+0% +$202 ﹤0.01% 4190
2022
Q3 		$618K Buy
177,711
+19,906
+13% +$76K ﹤0.01% 4158
2022
Q2 		$539K Buy
157,805
+4,571
+3% +$25.2K ﹤0.01% 4274
2022
Q1 		$1.4M Sell
153,234
-38,833
-20% -$590K ﹤0.01% 4105
2021
Q4 		$4.13M Buy
192,067
+36,052
+23% +$964K ﹤0.01% 3714
2021
Q3 		$5.1M Sell
156,015
-1,925
-1% -$70.5K ﹤0.01% 3646
2021
Q2 		$6.59M Sell
157,940
-11,304
-7% -$579K ﹤0.01% 3436
2021
Q1 		$11.1M Buy
169,244
+49,268
+41% +$3.44M ﹤0.01% 3095
2020
Q4 		$7.88M Buy
119,976
+769
+0.6% +$50.1K ﹤0.01% 3120
2020
Q3 		$6.47M Sell
119,207
-237
-0.2% -$18.1K ﹤0.01% 3018
2020
Q2 		$11.4M Buy
119,444
+3,929
+3% +$293K ﹤0.01% 2710
2020
Q1 		$5.93M Buy
115,515
+4,423
+4% +$462K ﹤0.01% 2897
2019
Q4 		$9.13M Buy
111,092
+11,700
+12% +$820K ﹤0.01% 2902
2019
Q3 		$8.5M Buy
99,392
+5,697
+6% +$608K ﹤0.01% 2899
2019
Q2 		$11.9M Buy
93,695
+1,994
+2% +$287K ﹤0.01% 2755
2019
Q1 		$16.5M Sell
91,701
-6,850
-7% -$991K ﹤0.01% 2590
2018
Q4 		$10.9M Buy
98,551
+2,441
+3% +$318K ﹤0.01% 2732
2018
Q3 		$13M Buy
96,110
+12,501
+15% +$1.72M ﹤0.01% 2793
2018
Q2 		$11.5M Buy
83,609
+2,715
+3% +$373K ﹤0.01% 2831
2018
Q1 		$11.2M Buy
80,894
+6,450
+9% +$878K ﹤0.01% 2784
2017
Q4 		$9.16M Buy
74,444
+3,854
+5% +$529K ﹤0.01% 2863
2017
Q3 		$9.63M Buy
70,590
+3,269
+5% +$493K ﹤0.01% 2824
2017
Q2 		$11.8M Buy
67,321
+2,959
+5% +$421K ﹤0.01% 2696
2017
Q1 		$7.72M Buy
64,362
+281
+0.4% +$29.2K ﹤0.01% 2865
2016
Q4 		$6.25M Buy
64,081
+512
+0.8% +$46.9K ﹤0.01% 2961
2016
Q3 		$5.97M Buy
63,569
+164
+0.3% +$16.4K ﹤0.01% 2916
2016
Q2 		$6.83M Sell
63,405
-4,375
-6% -$512K ﹤0.01% 2824
2016
Q1 		$8.13M Buy
67,780
+2,652
+4% +$279K ﹤0.01% 2723
2015
Q4 		$7.76M Buy
65,128
+1,864
+3% +$240K ﹤0.01% 2772
2015
Q3 		$10.8M Buy
63,264
+5,465
+9% +$1.05M ﹤0.01% 2573
2015
Q2 		$11.2M Buy
57,799
+3,170
+6% +$588K ﹤0.01% 2618
2015
Q1 		$8.1M Buy
54,629
+1,118
+2% +$170K ﹤0.01% 2748
2014
Q4 		$8.35M Buy
53,511
+609
+1% +$87.7K ﹤0.01% 2624
2014
Q3 		$7.59M Buy
52,902
+910
+2% +$132K ﹤0.01% 2622
2014
Q2 		$6.79M Buy
51,992
+1,211
+2% +$154K ﹤0.01% 2696
2014
Q1 		$6.22M Buy
50,781
+5,077
+11% +$550K ﹤0.01% 2718
2013
Q4 		$4.85M Sell
45,704
-2,206
-5% -$214K ﹤0.01% 2813
2013
Q3 		$5.38M Buy
47,910
+521
+1% +$59.1K ﹤0.01% 2704
2013
Q2 		$5.34M Buy
+47,389
New +$5.8M ﹤0.01% 2628

Other funds holding SRGA

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KOC
Koss-Olinger Consulting Gainesville, Florida $1.19B AUM 15.91% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Vanguard Group's SRGA Position: Q2 2023 in Review

Vanguard Group sold out of Surgalign Holdings, Inc. Common Stock (SRGA) in Q2 2023, closing a stake of 177,793 shares — an estimated $284K sold.

Vanguard Group first reported a position in SRGA in Q2 2013 and held it in 40 quarters. The position peaked at $16.5M in Q1 2019. 25 funds tracked by Wall St. Rank hold SRGA as of Q2 2023.

  • Vanguard Group reported no remaining Surgalign Holdings, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Vanguard Group sold 177,793 Surgalign Holdings, Inc. Common Stock shares in Q2 2023, an estimated $284K.
  • Vanguard Group first reported a position in Surgalign Holdings, Inc. Common Stock in Q2 2013 and held it in 40 quarters.
  • Vanguard Group's Surgalign Holdings, Inc. Common Stock position peaked at $16.5M in Q1 2019.
  • 25 funds tracked by Wall St. Rank held Surgalign Holdings, Inc. Common Stock as of Q2 2023.

Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.